Literature DB >> 30374431

Bilateral Medullary Thyroid Carcinoma in a 3-Year-Old Female Patient with Multiple Endocrine Neoplasia 2A Syndrome Undergoing Prophylactic Thyroidectomy: Should Current Guidelines Be Revised?

Abbas Al-Kurd1, David J Gross2, David Zangen3, Karine Atlan4, Haggi Mazeh1, Simona Grozinsky-Glasberg2.   

Abstract

BACKGROUND: Multiple endocrine neoplasia (MEN) 2A is an autosomal dominant disorder that results from a mutation in the RET proto-oncogene on chromosome 10. Almost all of the affected patients develop medullary thyroid carcinoma (MTC). The American Thyroid Association recommends prophylactic thyroidectomy in MEN 2A pediatric patients, with the age of the recommended thyroidectomy varying according to the codon mutation present.
OBJECTIVES: This report questions the reliability of the currently placed guidelines and whether the age threshold for prophylactic thyroidectomy in patients with known codon 634 mutations should be lowered, in parallel with an earlier evaluation of calcitonin levels in the serum.
METHODS: We report the preoperative diagnosis as well as operative and postoperative course of a 3-year-old female patient with MEN 2A (codon 634 mutation) who underwent prophylactic thyroidectomy. The postoperative histopathologic findings are presented and discussed.
RESULTS: Despite the prophylactic nature of the operation, in parallel with a borderline calcitonin increase in the serum, bilateral MTC was discovered on pathology.
CONCLUSION: It is likely that the current guidelines should be revised to recommend calcitonin screening and prophylactic thyroidectomy at an earlier age for MEN 2A patients with known codon 634 mutations.

Entities:  

Keywords:  Age; Guidelines; Incidental carcinoma; Medullary thyroid carcinoma; Multiple endocrine neoplasia 2A; Prophylactic thyroidectomy

Year:  2018        PMID: 30374431      PMCID: PMC6198771          DOI: 10.1159/000489170

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  16 in total

1.  Small medullary thyroid carcinoma: post-operative calcitonin rather than tumour size predicts disease persistence and progression.

Authors:  Katerina Saltiki; Gianna Rentziou; Kimon Stamatelopoulos; Georgios Georgiopoulos; Charalambos Stavrianos; Eirini Lambrinoudaki; Maria Alevizaki
Journal:  Eur J Endocrinol       Date:  2014-04-23       Impact factor: 6.664

2.  Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.

Authors:  Gabriela E Sanso; Horacio M Domene; RudazMariaC Garcia; Eduardo Pusiol; MondinoAnaK de; Maria Roque; Alejandro Ring; Hector Perinetti; Boris Elsner; Sonia Iorcansky; Marta Barontini
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

Review 3.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

4.  Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.

Authors:  Michael A Skinner; Jeffrey A Moley; William G Dilley; Kouros Owzar; Mary K Debenedetti; Samuel A Wells
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

5.  Hypercalcitoninemia in infancy.

Authors:  D B Cannarozzi; D D Canale; R K Donabedian
Journal:  Clin Chim Acta       Date:  1976-02-02       Impact factor: 3.786

Review 6.  Update multiple endocrine neoplasia type 2.

Authors:  Friedhelm Raue; Karin Frank-Raue
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

7.  Reference intervals for serum calcitonin in men, women, and children.

Authors:  Jean-Pierre Basuyau; Eric Mallet; Marcelle Leroy; Philippe Brunelle
Journal:  Clin Chem       Date:  2004-10       Impact factor: 8.327

8.  Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.

Authors:  Claudia Scollo; Eric Baudin; Jean-Paul Travagli; Bernard Caillou; Nicolas Bellon; Sophie Leboulleux; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

9.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

10.  Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study.

Authors:  Jennifer M J Schreinemakers; Menno R Vriens; Gerlof D Valk; Jan-Willem B de Groot; John T Plukker; Klaas M A Bax; Jaap F Hamming; Rob B van der Luijt; Daniel C Aronson; Inne H M Borel Rinkes
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.